Steve Aselage, Director at Acer Therapeutics Inc. (ACER), bought 10,000 shares at $2.15 ($21K) on 2021-12-09, disclosed to the SEC on 2021-12-13.
Open-market purchase of $21k ACER by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.15 | 2,016 | $4K | 21.0% |
| 2 | $2.04 | 7,984 | $16K | 79.0% |
| Total | $2.06 avg | 10,000 | $21K | 100% |
| Filing → |
| TVTX | SELL | 2022-05-12 | $113K | — | Filing → |
| TVTX | SELL | 2021-11-18 | $935K | — | Filing → |
| TVTX | SELL | 2021-11-09 | $262K | — | Filing → |